A Novel Phase 2 Double-blind, Randomized, Controlled Clinical Trial to Evaluate the Efficacy of Centrally Acting, Non-toxic ACE Inhibition in Cognitive Impairment Associated With SLE
Latest Information Update: 15 Feb 2024
At a glance
- Drugs Lisinopril (Primary) ; Benazepril
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 07 Feb 2024 Planned End Date changed from 1 Nov 2024 to 1 Nov 2025.
- 07 Feb 2024 Planned primary completion date changed from 1 Jan 2024 to 1 Jun 2025.
- 16 Dec 2022 Planned End Date changed from 1 Jul 2024 to 1 Nov 2024.